Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine

TY - JOUR

T1 - Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine

AU - Elder, D. H.

AU - Mohan, M.

AU - Cochrane, L.

AU - Charles, H.

AU - Lang, C. C.

N1 - Elder, Douglas H Mohan, Mohapradeep Cochrane, Lynda Charles, Helena Lang, Chim C 2015/3/27

PY - 2015

Y1 - 2015

N2 - To identify the prevalence and characteristics of recently hospitalized chronic heart failure (CHF) patients in community care who meet the indication for ivabradine.|A retrospective clinical audit of CHF patients recently hospitalized with acute decompensated heart failure (ADHF) and subsequently referred to the Tayside Heart Failure Nurse Liaison Service (THFNLS), a Scottish nurse-led community heart failure liaison service. Inclusion criteria were previous hospitalization with ADHF, subsequent referral to the THFNLS, data for ≥ 2 nurse visits, and a recorded pulse. The main outcome measure was the proportion of patients who meet the indicated criteria for ivabradine.|In the UK, ivabradine is indicated for CHF with systolic dysfunction in patients in sinus rhythm, with a heart rate ≥ 75 bpm, and NYHA class II-class IV. After up-titration of a beta-blocker, 19.0% of patients in the full dataset (158 of 830) met the indication for ivabradine at the last visit. Of these "ivabradine-suitable" patients, 101 of 158 (63.9%) received bisoprolol "at any time" during the study period; 20 of 158 (12.7%) achieved the target dose (10 mg daily); 52 of 158 (32.9%) received 5 mg or 7.5 mg daily; and 93 of 158 (58.9%) received

AB - To identify the prevalence and characteristics of recently hospitalized chronic heart failure (CHF) patients in community care who meet the indication for ivabradine.|A retrospective clinical audit of CHF patients recently hospitalized with acute decompensated heart failure (ADHF) and subsequently referred to the Tayside Heart Failure Nurse Liaison Service (THFNLS), a Scottish nurse-led community heart failure liaison service. Inclusion criteria were previous hospitalization with ADHF, subsequent referral to the THFNLS, data for ≥ 2 nurse visits, and a recorded pulse. The main outcome measure was the proportion of patients who meet the indicated criteria for ivabradine.|In the UK, ivabradine is indicated for CHF with systolic dysfunction in patients in sinus rhythm, with a heart rate ≥ 75 bpm, and NYHA class II-class IV. After up-titration of a beta-blocker, 19.0% of patients in the full dataset (158 of 830) met the indication for ivabradine at the last visit. Of these "ivabradine-suitable" patients, 101 of 158 (63.9%) received bisoprolol "at any time" during the study period; 20 of 158 (12.7%) achieved the target dose (10 mg daily); 52 of 158 (32.9%) received 5 mg or 7.5 mg daily; and 93 of 158 (58.9%) received

KW - Acute Disease Aged Aged, 80 and over Benzazepines Bisoprolol Cardiovascular Agents Chronic Disease Clinical Protocols Drug Utilization Female Heart Failure Hospitalization Humans Ivabradine Male Medication Therapy Management Middle Aged Retrospective Stud

U2 - 10.1111/1755-5922.12117

DO - 10.1111/1755-5922.12117

M3 - Article

SN - 1755-5922

VL - 33

SP - 104

EP - 108

JO - Cardiovasc Ther

JF - Cardiovasc Ther

IS - 3

ER -